drugset / Trial / NCT04808856
Treatment of Refractory Gout With ACTH or Methylprednisolone
RandomizedParallel-groupOpen-labelTreatment
Summary
To clarify the therapeutic effect and safety evaluation of ACTH in refractory gouty arthritis and special population, and to explore its mechanism of action.
Timeline
- Start
- 2021-04-01
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 25 iu | — |
| Comparator | Methylprednisolone | Other / unclassified | 40 mg | — |